RecruitingNot ApplicableNCT05738720

Effect of Home Based Pulmonary Rehabilitation on Exacerbation and Hospital Admission in Severe COPD

The Effect of Close Follow-Up Home Based Pulmonary Rehabilitation on Exacerbation Frequency and Hospital Admission in Severe COPD Cases

Sponsor

Saglik Bilimleri Universitesi

Enrollment

24 participants

Start Date

Feb 1, 2023

Study Type

INTERVENTIONAL

Conditions

COPD Exacerbation

Summary

The study is a randomized controlled trial. The cases will be divided into two groups as the Homespirometer group and the control group. Breathing exercises, aerobic exercise and peripheral muscle strengthening will be performed in both groups. A home-type spirometer will be given to the homespirometer group and it will be requested to send the spirometric measurement every week. The cases will be called to the hospital for control and evaluated at baseline, 3rd, 6th and 12th months. Evaluations include assessments such as exercise capacity measurement, muscle strength measurement, disease attack frequency, symptom scoring.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a home-based pulmonary rehabilitation program delivered via smartphone can reduce hospital admissions and flare-ups (called exacerbations) in people with severe COPD (a chronic lung disease causing breathlessness). **You may be eligible if...** - You are between 18 and 75 years old - You have been diagnosed with severe COPD (stages C or D according to GOLD guidelines) - You have shortness of breath with physical activity - Your COPD has been stable (no infection or flare-up in the past 4 weeks) - You are comfortable using a smartphone and a breathing device (spirometer) after some training **You may NOT be eligible if...** - You have serious additional health conditions like unstable heart disease, connective tissue disorders, or require high-flow oxygen (more than 3–4 L/min) - You have a history of fainting during exercise or any condition that prevents safe exercise - You have participated in a pulmonary rehabilitation program in the past 12 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETeknikel Spirobank Home Type Respiratory Function Tester (Homespirometer)

Pulmonary Function Test (PFT): Pulmonary function test will be performed with a Teknikel Spirobank home pulmonary function test device. In the study group, the patient will make weekly measurements at home and send it to the physiotherapist. In the control group, evaluation will be made with the device only at the beginning and end of the treatment.

OTHERExercise Programme

Exercise Program * Breathing exercises: Chest, diaphragmatic breathing and lower basal breathing exercises will be performed with 10 repetitions. * Resistance exercises: Strengthening exercises will be performed on the major muscle groups of the upper and lower extremities by using medium hardness therabant. During the exercises, the patient's fatigue and dyspnea levels will be questioned using the Borg scale, and breaks will be given when necessary. The exercises will be performed with a medium-hardness therabband. Exercises will be given for the upper extremity and lower extremity, and the patients will be asked to do 10 repetitions. * Gait training: In line with the data obtained from the 6-minute walking test, gait training will be given on flat ground at 60% workload (land-based walking). Patients will be allowed to walk on flat ground at 60% workload, at a time calculated based on the results of the 6-minute walk test.